Αποτελέσματα Αναζήτησης
29 Ιαν 2020 · Hormone therapy is highly effective for the management of vasomotor symptoms in postmenopausal women; vaginal estrogen is used for genitourinary symptoms only. Hormone therapy is not...
- Menopause Management
Hormone replacement therapy and cancer mortality in women...
- Menopause Management
Hormone replacement therapy (HRT) at different doses rapidly normalizes turnover, preserves bone mineral density (BMD) at all skeletal sites, leading to a significant, reduction in vertebral and non-vertebral fractures.
6 Δεκ 2022 · You take the medication to replace the estrogen that your body stops making during menopause. Hormone therapy is most often used to treat common menopausal symptoms, including hot flashes and vaginal discomfort. Hormone therapy has also been proved to prevent bone loss and reduce fracture in postmenopausal women.
18 Σεπ 2019 · Abstract. Purpose. The aim of this work is to provide evidence-based guidance on the management of osteoporosis in survivors of adult cancer. Methods. ASCO convened a multidisciplinary Expert Panel to develop guideline recommendations based on a systematic review of the literature. Results.
13 Φεβ 2023 · Estrogen may have plaque-destabilizing and other adverse effects in the setting of advanced atherosclerosis, but it provides an appropriate and safe option for treatment of menopausal symptoms when initiated in healthy women <60 years of age or within 10 years of menopause onset.
12 Οκτ 2020 · HRT should be considered the first-line therapeutic intervention for the prevention and treatment of osteoporosis in women with premature ovarian insufficiency (POI) and menopausal women below 60 years of age, particularly those with menopausal symptoms. •.
We advise estrogen-progestin replacement therapy as prophylaxis against osteoporosis in all postmenopausal women at high risk for this disorder and for hot flushes, genitourinary symptoms, and changes in mood, in patients who have no contraindications to this therapy. Because no specific age for initiation of estrogen replacement therapy or ...
